Cargando…
Advances in the prevention, management, and treatment of community-acquired pneumonia
Despite the availability of powerful antibiotics, community-acquired pneumonia (CAP) remains one of the leading reasons for morbidity and mortality worldwide, and despite the availability of powerful antibiotics, there has been only little improvement in case fatality rates for many years. Consequen...
Autores principales: | Pletz, Mathias W, Welte, Tobias, Ott, Sebastian R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990450/ https://www.ncbi.nlm.nih.gov/pubmed/21173853 http://dx.doi.org/10.3410/M2-53 |
Ejemplares similares
-
Advances in the prevention, management, and treatment of community-acquired pneumonia
por: Pletz, Mathias W., et al.
Publicado: (2016) -
Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity
por: Pletz, Mathias W, et al.
Publicado: (2014) -
Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study
por: Lepper, Philipp M, et al.
Publicado: (2012) -
Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
por: Pletz, Mathias W, et al.
Publicado: (2010) -
Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
por: Zobel, Katrin, et al.
Publicado: (2012)